131. Antiviral NL-CVX1 Efficiently Blocks Infection of SARS-CoV-2 Viral Variants of Concern (VOC)

por Su, Wen, Walker, Matthew, Rebelo, Maria, Tang, Cong, Coelho, Ana R, Tatalick, Laurie, Riley, Marianne, Yu, Kevin, Blancas-Mejia, Luis M, Silva, Daniel-Adriano, Shoultz, David, Bernardes, Goncalo, Yen, Hui-Ling
Publicado 2021

De Novo Human Angiotensin-Converting Enzyme 2 Decoy NL-CVX1 Protects Mice From Severe Disease After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

por Rebelo, Maria, Tang, Cong, Coelho, Ana R, Labão-Almeida, Carlos, Schneider, Matthias M, Tatalick, Laurie, Ruivo, Pedro, de Miranda, Marta Pires, Gomes, Andreia, Carvalho, Tânia, Walker, Matthew J, Ausserwoeger, Hannes, Pedro Simas, J, Veldhoen, Marc, Knowles, Tuomas P J, Silva, Daniel-Adriano, Shoultz, David, Bernardes, Gonçalo J L
Publicado 2023